Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 638

1.

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.

Ross RG.

Am J Psychiatry. 2006 Jul;163(7):1149-52. No abstract available.

PMID:
16816217
2.

Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.

Kraemer M, Uekermann J, Wiltfang J, Kis B.

Clin Neuropharmacol. 2010 Jul;33(4):204-6. doi: 10.1097/WNF.0b013e3181e29174. Review.

PMID:
20571380
3.

Psychotic side effects of psychostimulants: a 5-year review.

Cherland E, Fitzpatrick R.

Can J Psychiatry. 1999 Oct;44(8):811-3.

PMID:
10566114
4.

Methylphenidate transdermal system.

Mays DA, Findling R.

J Am Acad Child Adolesc Psychiatry. 2005 Dec;44(12):1223. No abstract available.

PMID:
16292112
5.

Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder.

Biederman J, Spencer T.

J Atten Disord. 2002;6 Suppl 1:S101-7.

PMID:
12685524
6.
7.

Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.

Gadow KD, Sverd J.

Adv Neurol. 2006;99:197-207. Review. No abstract available.

PMID:
16536367
8.

[Infantile psychosis secondary to methylphenidate].

Fernández-Fernández MA, Rufo-Campos M, Mateos-Checa R, Muñoz-Cabello B, Madruga-Garrido M, Blanco-Martínez B.

Rev Neurol. 2011 Apr 1;52(7):446-7. Spanish. No abstract available.

9.

Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.

Kummer A, Teixeira A.

Australas Psychiatry. 2008 Dec;16(6):458-9. No abstract available.

PMID:
19034996
10.

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.

Clin Ther. 2009 Aug;31(8):1844-55. doi: 10.1016/j.clinthera.2009.08.002.

PMID:
19808143
11.

Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.

Pae CU.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1149-50; author reply 1151-2. No abstract available.

PMID:
17493730
12.

Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.

Merkel RL Jr, Kuchibhatla A.

Expert Opin Drug Saf. 2009 Nov;8(6):655-68. doi: 10.1517/14740330903279956. Review.

PMID:
19785509
13.

Transdermal methylphenidate (Daytrana) for ADHD.

[No authors listed]

Med Lett Drugs Ther. 2006 Jun 19;48(1237):49-51. No abstract available.

PMID:
16785850
14.

Pharmacological management of treatment-induced insomnia in ADHD.

Kratochvil CJ, Lake M, Pliszka SR, Walkup JT.

J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):499-501. Review. No abstract available.

PMID:
15843773
15.

Naturalistic long-term use of methylphenidate in bipolar disorder.

Lydon E, El-Mallakh RS.

J Clin Psychopharmacol. 2006 Oct;26(5):516-8.

PMID:
16974196
16.

Focalin XR for ADHD.

[No authors listed]

Med Lett Drugs Ther. 2009 Mar 23;51(1308):22-4. No abstract available.

PMID:
19305368
17.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Review.

PMID:
19470858
18.

Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.

Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.

J Clin Psychopharmacol. 2009 Jun;29(3):239-47. doi: 10.1097/JCP.0b013e3181a390ce.

PMID:
19440077
19.

Quillivant XR--an extended release oral suspension of methylphenidate.

[No authors listed]

Med Lett Drugs Ther. 2013 Feb 4;55(1409):10-1. No abstract available.

PMID:
23381227
20.

How high a dose of stimulant medication in adult attention deficit hyperactivity disorder?

Sachdev PS, Trollor JN.

Aust N Z J Psychiatry. 2000 Aug;34(4):645-50. Review.

PMID:
10954396
Items per page

Supplemental Content

Support Center